.png)
.png)
Promising results from cardiac fibrosis studies with MRX1
Ananda Developments PLC, a clinical-stage life sciences company focused on the development of CBD based therapies for the treatment of a range of complex inflammatory pain conditions, is delighted to share promising results from recent preclinical studies investigating the efficacy of MRX1 (Patent Pending) in treating cardiac fibrosis and heart failure with preserved ejection fraction (HFpEF).
Valneva Scotland appoints science communications consultancy, Perceptive Communicators
Glasgow-based specialist communications consultancy, Perceptive Communicators, has announced its appointment to provide strategic communications services for Valneva Scotland.
Coulter Partners places Head of Sales North America at Pelago Bioscience
Coulter Partners recently partnered with Pelago Bioscience and is pleased to announce the placement of Brian Jarecki, PhD as Head of Sales North America.
Discovery Park Innovation Summit showcases Kent’s ambition to be a leader in healthy ageing
Discovery Park welcomed experts in healthy ageing to its Innovation Summit on 20th June, calling for the life science network in Kent to join forces to make the county a leader in healthy ageing and longevity.
Cryoport Systems officially launches global supply chain hub in Stevenage, U.K.
Cryoport Systems' new global Supply chain hub in Stevenage will enhance the company's ability to provide comprehensive supply chain and logistics solutions for advanced therapy manufacturers in the UK and across Europe.
Engitix appoints two additional international biotech industry leaders as Scientific Advisors
Engitix Ltd announced the appointment of two biotech industry leaders as Scientific Advisors: Adrian S. Ray, PhD, and Scott Turner, PhD.
RoslinCT appoints Professor Sir Peter Mathieson and Alexander Vos as Non-Executive Directors
RoslinCT is pleased to announce the appointment of Professor Sir Peter Mathieson MB BS (Hons), PhD, FRCP, FRCPE, FMedSci, FRSE, FRSA and Alexander Vos as new Non-Executive Directors.
Rare Disease Community Event – meeting report
On 6 June 2024, the MRC National Mouse Genetics Network (NMGN) and the Mary Lyon Centre at MRC Harwell (MLC) hosted a Resources and Funding Opportunities in Rare Diseases event at the Advance Training Centre aimed at sharing information on resources and funding opportunities in the specific area of preclinical and clinical research and fostering new collaborative initiatives between academia, industry and advocacy/patient groups.
Macomics and Institute of Oncology Research announce macrophage collaboration in prostate cancer
Laboratory of Prof. Andrea Alimonti at IOR (Institute of Oncology Research, Bellinzona, Switzerland) and Macomics to bring together expertise on myeloid-derived suppressor cells in prostate cancer mouse model systems
Discovery Park gears up for annual Innovation Summit with final spots remaining
Discovery Park, Kent’s thriving life science and innovation community, is preparing to welcome 300 healthcare innovators to its campus on Thursday 20th June for its second annual Innovation Summit, with only final spots remaining.